BioNeutra Global Corporation
BGA.V
TSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -90.36% | -129.88% | -183.93% | 1.34% | 51.49% |
| Total Depreciation and Amortization | -33.64% | -34.29% | -30.95% | -30.97% | 16.30% |
| Total Amortization of Deferred Charges | -7.16% | -7.16% | -7.16% | -7.16% | 3.59% |
| Total Other Non-Cash Items | -52.78% | 601.83% | 804.91% | -46.24% | -88.11% |
| Change in Net Operating Assets | 420.55% | 360.47% | -7.47% | 188.04% | -13.65% |
| Cash from Operations | 630.60% | 21.00% | -113.18% | 1,042.54% | 111.39% |
| Capital Expenditure | 106.88% | 86.17% | 74.84% | 58.01% | 24.46% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -- | -- | -86.72% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.49% | 45.56% | -213.13% | -- | -1,306.38% |
| Cash from Investing | 104.43% | 75.02% | 59.46% | 30.79% | -29.41% |
| Total Debt Issued | -33.52% | 251.29% | 3.67% | 3.67% | 59.86% |
| Total Debt Repaid | 31.73% | 68.62% | 16.13% | 7.91% | 12.12% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 21.10% | -789.40% | -44.41% | -25.62% | -2.24% |
| Cash from Financing | 9.06% | 26.17% | -0.93% | -4.07% | 66.98% |
| Foreign Exchange rate Adjustments | -790.15% | -252.95% | -1,426.98% | -167.78% | -77.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 145.95% | -369.19% | -170.37% | -40.78% | 93.03% |
